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Abstract 
Introduction: The aim of the study was to determine which microperimetry and contrast sensitivity test parameters would prove the 
most valuable during diagnosing optic chiasm compression due to pituitary adenomas.
Material and methods: A control group comprised healthy individuals (Group 1). Patients with pituitary macroadenoma were divided 
into two groups: Group 2 — absent optic chiasm compression; and Group 3 — present optic chiasm compression detected on contrast-
enhanced magnetic resonance imaging (MRI). Each group comprised 20 patients (40 eyes), i.e. a total of 60 patients (120 eyes) were 
examined. A complete ocular examination, intraocular pressure, microperimetry, contrast sensitivity test, kinetic Goldmann visual field, 
and static Octopus visual field test were performed.
Results: Group 1 and 2 variables showed no statistically significant differences with respect to the mean sensitivity (MS) and mean defect 
(MD) in microperimetry. After dividing the microperimetry area into quadrants, a difference was shown in the mean sensitivity of the 
lower-nasal quadrant (MS LN) and mean defect of the lower-nasal quadrant (MD LN) between those groups. Receiver operating charac-
teristic (ROC) curves analysis revealed that the microperimetry parameter — MS LN as well as row D and E contrast sensitivity test could 
be highly specific in the assessment of early damage of the optic nerve in patients suffering from pituitary adenoma.
Conclusions: Microperimetry and contrast sensitivity test are non-invasive diagnostic investigations adjunctive to MRI, which facilitate 
detection of early chiasmal compression caused by pituitary adenomas. (Endokrynol Pol 2019; 70 (3): 241–247)
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Introduction
Pituitary adenomas are a heterogeneous group of tu-
mours in terms of hormone secretion and growth char-
acteristics [1, 2]. With such heterogeneity of tumours, 
no obvious and clear treatment algorithm is present [3]. 
The majority of pituitary adenomas are sporadic, and 
only 5% of them occur in a familial setting [4]. 
Although some pituitary tumours remain clini-
cally silent for a long time and may grow slowly for 
years, other tumours may present aggressive and 
rapid growth. These are usually macroadenomas with 
invasive growth, high recurrence rate, and resistance 
to repeated treatments [5, 6].
Microperimetry, also known as fundus perimetry, 
is characterised by significantly higher central retinal 
sensitivity compared to conventional static perimetry. 
It allows detection of the slightest changes in retinal 
sensitivity even when a fundus examination does not 
reveal any abnormalities [7]. Mean retinal sensitivity 
is a valuable complementary measurement to visual 
acuity. 
Contrast sensitivity test is an important test for func-
tional vision, including the Functional Acuity Contrast 
Test (FACT) developed by Arthur P. Ginsburg. In this 
examination the patient is asked to identify the orien-
tation of lines in a grating pattern at various levels of 
contrast and spatial frequency.
Contrast-enhanced NMR is the gold standard in 
the diagnosis of adenomas and helps precisely define 
tumour boundaries and its relationship with adjacent 
structures, such as the optic chiasm [8]. High sensitivity 
allows detection of small tumours (microadenomas). 
When growing, macroadenomas extend into the su-
prasellar region and towards the optic chiasm, they 
may lift up third ventricle floor, obstruct the foramen 
Endokrynologia Polska
DOI: 10.5603/EP.a2019.0003
Volume/Tom 70; Number/Numer 3/2019
ISSN 0423–104X
Monika Sarnat-Kucharczyk, Department of Ophthalmology, School of Medicine in Katowice, Medical University of Silesia,  
ul. Ceglana 35, 40–514 Katowice, Poland, tel: (+48) 605 375 476, fax: (+48) 32 251 84 37; monikasarnat@vp.pl
242
O
R
IG
IN
A
L
 P
A
P
E
R
Microperimetry and contrast sensitivity test in pituitary adenomas Monika Sarnat-Kucharczyk et al.
-Wallis test with post hoc Dunn’s test was used to compare outcomes 
among more than two groups. The t-test was used to compare 
normal distributions, and, if needed, the Bonferroni post-hoc test. 
ROC analysis was applied to compare different variables used in 
the diagnosis of pituitary macroadenomas.
Results
A total of 120 eyes of 60 participants (mean age ± SD: 
46.48 ± 12.47 years, 24 males, 36 females) were included 
in the study. The groups did not differ significantly 
with respect to the participants’ age. Tables I–III pres-
ent the most important study variables in the control 
and study groups.  
Best-corrected distance visual acuity was 1.0, 0.99, 
and 0.97 in Group 1, 2, and 3, respectively. Statistically 
significant differences were only noted between Group 
1 and 3 (p = 0.005351). Best-corrected near visual acuity 
was 0.5 in Group 1, 0.52 in Group 2, and 0.56 in Group 
3; again, statistically significant differences were only 
seen between Group 1 and 3 (p = 0.000848).
To the mean sensitivity of the macula by micrope-
rimetry was 18.91 dB, 18.3 dB, and 13.39 dB in Group 
1, 2, and 3, respectively (Fig. 2). The mean defect was: 
–1.07 dB in Group 1, –1.66 dB in Group 2, and –5.1 dB 
in Group 3 (Fig. 3).
Group 1 and 2 did not differ significantly with 
respect to MS and MD by microperimetry. However, 
after dividing the microperimetry area into quadrants, 
a difference was demonstrated in MS LN and MD LN 
between those groups. Figure 4 depicts a comparison 
of MS LN in the study and control groups.
of Monro, or extend sideways towards the cavernous 
sinus or downwards to the sphenoid sinus [9]. 
Kinetic visual field (VF) is very useful at advanced 
stages of the disease and in patients who have difficul-
ties in performing a static VF. Although Octopus static 
perimetry test is helpful in the diagnosis of pituitary 
tumours, it may not reveal early optic nerve damage 
[10] and it should be noted that prolonged compression 
to the optic chiasm may produce deep and irreversible 
visual field defects [11].
The aim of the study was to determine which mi-
croperimetry and contrast sensitivity test parameters 
would prove the most valuable during diagnosing 
optic chiasm compression due to pituitary adenomas.
Material and methods
The study was consistent with the principles of the Declaration of 
Helsinki and was approved by the Ethics Committee of the Medi-
cal University of Silesia, Katowice, Poland. All the subjects gave 
informed consent to participate in the research.
Forty patients (80 eyes) with pituitary macroadenoma were enrolled 
in the study. The control group (Group 1) included 20 healthy 
patients — 11 women and nine men (40 eyes). Patients with mac-
roadenoma were divided into two groups: Group 2 (11 women 
and 9 men) — absent optic chiasm compression, Group 3 (14 
women and 6 men) – present optic chiasm compression detected 
on contract-enhanced NMR. A total of 60 patients (120 eyes) aged 
46.48 ± 12.47 years were examined.
The inclusion criteria for study groups were as follows: 
 — informed consent to participate in the study; 
 — pituitary macroadenoma detected on contrast-enhanced NMR; 
 — normal intraocular pressure; 
 — transparency of the ocular media; 
 — no myopia or hyperopia ≥ 4 dioptres, or astigmatism ≥ 2 dioptres; 
 — no corneal, lens, or retinal abnormalities; 
 — no history of ocular surgery; 
 — no systemic diseases considered contraindications to micrope-
rimetry or contrast sensitivity test; 
 — no severe visual defects precluding microperimetry or contrast 
sensitivity test. The participants reported no addictions.
All subjects participating in the study underwent ophthalmic 
examination of both eyes, including near and distance best-
corrected visual acuity, slit lamp examination of the anterior and 
posterior segments, microperimetry (MP-1, Nidek Technologies, 
Italy, pattern: macula 12° 10 dB, stimulus: Goldmann III, 200 ms), 
Functional Acuity Contrast Test (FACT, Optec 6500, Stereo Opti-
cal Co. Inc., Chicago, IL, USA), kinetic VF (Goldmann perimeter, 
Haag-Streit Inc., Bern, Switzerland, stimulus: 4 III), and static VF 
(Octopus 1-2-3 perimeter, Haag-Streit Inc., Koenic, Switzerland, 
strategy: TOP).
Division of the examined macular region into quadrants, not avail-
able in the MP-1 software, enabled us to accurately assess the central 
retinal sensitivity of each quadrant (Fig. 1).
The aim of the study was to determine which microperimetry 
and contrast sensitivity test parameters would prove the most 
valuable during diagnosing chiasmal compression due to pituitary 
adenomas.
Statistical analysis
P value < 0.05 was determined as statistically significant. The 
Shapiro-Wilk test and Kolmogorov-Smirnov test were performed to 
test for normality. Differences between two groups were compared 
with the non-parametric Mann-Whitney U test, while the Kruskal-
Figure 1. Division of the examined macular region by 
microperimetry into four quadrants
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The average duration of the microperimetry test for 
one eye was 8 min 30 s in Group 1, 9 min 4 s in Group 2, 
and 10 min 56 s in Group 3. No statistically significant dif-
ferences were noted between Group 1 and 2. Statistically 
significant differences were revealed between Group 1 
and 3 (p = 0.000113) and Group 2 and 3 (p = 0.000120).
Group 1 participants had normal contrast sensitivity 
(rows A–E). In the remaining two groups a reduction 
was noted in all spatial frequencies with the lowest 
values obtained in Group 3. A comparison of contrast 
sensitivity between Group 1 and 2 as well as Group 1 
and 3 revealed statistically significant differences at all 
spatial frequencies. An analysis of the same variables 
in Group 2 and 3 showed statistically significant differ-
ences but only in rows A, C, D.
An analysis of MS and MD values obtained by 
microperimetry and Octopus VF did not reveal statis-
tically significant differences between Group 1 and 2. 
However, after dividing the examination area into four 
quadrants, statistically significant intergroup differ-
ences in the lower-nasal quadrant were only revealed 
on microperimetry and not Octopus VF. 
The results of kinetic VF test revealed statistically 
significant differences in the temporal visual field be-
tween Group 1 and 3 (p = 0.000113). No significant 
differences were noted between Group 1 and 2. 
Table I. Variables in Group 1
Group 1 N Mean SD Median Min Max
Microperimetry [dB]
MS 40 18.91 0.60 18.90 17.80 20.00
MD 40 –1.07 0.57 –1.10 –2.20 0
MS LN 40 18.96 0.68 18.93 17.45 20.00
Contrast sensitivity test
(patch scores)
Row A 40 6.44 1.22 5.70 5.00 8.70
Row B 40 6.67 1.21 6.70 4.00 8.70
Row C 40 6.89 0.81 7.00 5.00 8.00
Row D 40 6.03 1.01 6.00 4.00 8.00
Row E 40 4.04 1.43 4.00 2.00 7.00
Static VF — Octopus [dB]
MS 40 28.36 1.34 28.25 24.30 30.10
MD 40 0.15 0.99 0.10 –1.70 3.00
MS LN 40 28.36 1.36 28.35 25.00 30.50
Kinetic VF — temporal part [degrees] 40 83.50 4.83 85.00 70.00 90.00
N — number; SD — standard deviation; Min — minimum; Max — maximum; dB – decibels; MS — mean sensitivity; MD — mean defect; MS LN — mean sensitivity 
lower-temporal, VF — visual field
Table II. Variables in Group 2
Group 2 N Mean SD Median Min Max
Microperimetry [dB]
MS 40 18.3 0.94 18.15 16.20 19.50
MD 40 –1.66 1.12 –1.65 –3.70 2.10
MS LN 40 17.49 1.04 17.40 15.63 19.38
Contrast sensitivity test 
(patch scores)
Row A 40 4.80 1.36 5.00 1.70 8.30
Row B 40 4.98 1.67 5.00 1.00 8.00
Row C 40 5.00 1.85 5.00 0.30 8.70
Row D 40 3.25 1.66 3.15 0.30 7.00
Row E 40 1.50 1.24 1.00 0 5.00
Static VF  
— Octopus [dB]
MS 40 26.28 1.78 26.30 22.80 29.80
MD 40 2.18 2.09 2.10 –1.70 7.00
MS LN 40 25.16 2.84 25.00 16.00 30.00
Kinetic VF — temporal part [degrees] 40 79.00 6.52 80.00 60.00 90.00
N — number; SD — standard deviation; Min — minimum; Max — maximum; dB – decibels; MS — mean sensitivity; MD — mean defect; MS LN — mean sensitivity 
lower-temporal, VF — visual field
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Group 3 exhibited a strong correlation between 
MS LN on microperimetry and temporal visual field 
(r = 0.914; Fig. 5). In Group 1 and 2 the relationship 
between these variables was not that strong.
Receiver operating characteristic curve analysis 
included MS LN by microperimetry as well as rows D 
and E by contrast sensitivity test. A comparison of the 
ROC curves between Group 1 and 2 revealed the largest 
area under the curve (AUC) for MS LN (AUC= 0.856). 
The cut-off value was ≤ 17.9 with 67.5% sensitivity and 
95% specificity. In contrast sensitivity test the most in-
formative were row D (AUC = 0.918) with the cut-off 
value ≤ 4.3 and 80% sensitivity, 92.5% specificity and 
row E (AUC = 0.856) with the cut-off value ≤ 1.7 and 
65% sensitivity, 100% specificity (Fig. 6).
Discussion
Pituitary adenomas can not only lead to different en-
docrine disorders but tend also to be a serious threat 
to vision. As a result of the mass effect associated with 
tumour growth and invasion to adjacent structures, 
these tumours may cause loss of visual acuity and VF 
defects [12].
The image passing through the lens and falling 
on the retina is inverted, both horizontally and verti-
Table III. Variables in Group 3
Group 3 N Mean SD Median Min Max
Microperimetry [dB]
MS 40 13.39 2.91 14.25 7.60 18.60
MD 40 –5.10 2.65 –5.40 –9.00 5.70
MS LN 40 11.61 4.65 13.63 2.70 17.70
Contrast sensitivity test 
(patch scores)
Row A 40 4.05 1.34 4.15 1.00 7.00
Row B 40 4.29 1.73 4.50 0.30 7.30
Row C 40 3.84 1.83 4.00 0 7.70
Row D 40 1.91 1.62 2.00 0 5.30
Row E 40 0.90 1.10 0.15 0 3.70
Static VF  
— Octopus [dB]
MS 40 19.75 4.42 20.65 9.70 27.00
MD 40 8.26 4.92 6.50 1.30 24.40
MS LN 40 16.09 3.58 16.20 7.00 24.90
Kinetic VF — temporal part [degrees] 40 48.00 31.86 60.00 0 90.00
N — number; SD — standard deviation; Min — minimum; Max — maximum; dB – decibels; MS — mean sensitivity; MD — mean defect; MS LN — mean sensitivity 
lower-temporal; VF — visual field
Figure 2. Comparison of MS by microperimetry in three groups. 
MS — mean sensitivity
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Figure 3. Comparison of MD by microperimetry in three groups. 
MD — mean defect
0
–1
–2
–3
–4
–5
–6
–7
M
D
 —
 m
ic
ro
p
e
ri
m
e
tr
y
Group 1 Group 2 Group 3
Mean            Mean ± SE            Mean ± 1.96 SE
245
Endokrynologia Polska 2019; 70 (3)
O
R
IG
IN
A
L
 P
A
P
E
R
cally. Therefore, the upper-temporal quadrant of VF is 
equivalent to the lower-nasal quadrant of the retina. 
According to Anik, relative or absolute scotomata first 
develop in the upper-temporal quadrant of VF resulting 
from a tumour compressing the lower-anterior portion 
of the optic chiasm. Subsequently, field deficits develop 
in lower-temporal, lower-nasal, and upper-nasal quad-
rants [13]. The results of our study showed a similar 
sequence in microperimetry and static Octopus VF.
Microadenomas or small macroadenomas may dis-
turb blood supply to the optic chiasm and cause VF de-
fects, a phenomenon referred to as intrasellar pressure 
syndrome [14]. Therefore, we recommend performing 
microperimetry and contrast sensitivity test not only in 
people affected by pituitary macroadenoma but also in 
those with smaller pituitary tumours. 
There are many limitations to manual kinetic 
perimetry, e.g. experience of the investigator, diverse 
response of the patient caused by fatigue, lack of 
standardisation parameters, and poor repeatability 
[15]; hence, no accurate assessment of the central VF 
is possible [16]. Shen et al. concluded that static vi-
sual field perimetry was more sensitive than manual 
Goldmann kinetic perimetry in patients with pitu-
itary adenomas [17], especially in the early stages of 
the disease [18]. Our results also revealed that the 
Goldmann perimeter may fail to detect minimal optic 
chiasm involvements. Hirai et al. examined a group of 
patients with optic chiasm lesions using a scanning la-
ser ophthalmoscope, a forerunner of microperimetry; 
they demonstrated that conventional perimetry was 
not capable of accurate assessment of central retinal 
sensitivity within 3° of the fixation point [19]. Micrope-
rimetry, on the other hand, offers several advantages; 
it allows accurate topographic correlation between 
retinal area details and its light sensitivity [20].
Figure 4. Comparison of MS LN by microperimetry in 
three groups. MS LN — mean sensitivity lower-temporal; 
SE — standard error
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Figure 5. Correlation between MS LN on microperimetry and 
temporal part of kinetic visual field in Group 3. MS LN — mean 
sensitivity lower-temporal; CI — confidence interval
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Figure 6. Receiver operating characteristic (ROC) curve analysis of MS LN by microperimetry, rows D and E by contrast sensitivity 
test. MS LN — mean sensitivity lower-temporal
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Due to considerable interest in microperimetry, 
the number of publications in this area continues 
to increase. However, literature on microperimetry 
and FACT in patients with pituitary adenomas is ex-
tremely scarce; in fact, there are only two reports on 
microperimetry in patients with pituitary adenoma 
[21]. On one hand this offers a unique opportunity 
for further studies, and on the other it is difficult to 
compare the observation of our 40 patients with two 
case reports. 
Furthermore, there are no reports on microperim-
etry in patients with pituitary macroadenomas but no 
evidence of obvious chiasmal compression on MRI. To 
the best of our knowledge, our study is one of the first 
to describe the application of microperimetry and FACT 
in a group of patients with pituitary adenomas.
Although microperimetry measures retinal sensitiv-
ity at specific points, it does not reveal the MS or MD of 
each quadrant. In order to accurately assess the disor-
ders caused by chiasmal compression, we divided the 
examined area into quadrants. In comparison to Octo-
pus VF, microperimetry showed statistically significant 
differences in MS LN between Group 1 and 2. Patients 
with pituitary macroadenomas but no signs of chiasmal 
compression on NMR may be at risk for optic nerve 
damage, which can be revealed by microperimetry.
Pituitary adenomas may cause bitemporal absolute 
scotomata while the nasal visual field remains relatively 
intact. It is therefore crucial that each quadrant should 
be individually assessed. An analysis of lower-nasal 
quadrant parameters is of particular importance be-
cause it is the first quadrant to become affected by 
pituitary adenomas. Until now there have been no 
reports on microperimetry changes in individual retinal 
quadrants in this group of patients.
In the absence of macular disease, microperimetry 
facilitates accurate assessment of central retinal sensi-
tivity reduction, secondary to the loss of ganglion cells 
and their axons [22]. Fundus perimetry complements 
neuro-ophthalmic examination including visual acuity, 
colour vision, and conventional VF test [23]. 
The main limit of microperimetry is the necessity 
to first obtain high-quality images of the fundus in the 
infrared in order to superimpose the acquired sensitiv-
ity data [24]. In our study we did not encounter any 
problems obtaining infrared images because the fundus 
view was not obscured by ocular media opacities in any 
of the patients.
Microperimeter MP-1 is an interesting diagnostic 
tool for the detection of early damage to the visual path-
way in patients with pituitary adenomas. In subclini-
cal forms of these tumours, microperimetry facilitates 
detection of abnormalities and allows monitoring of 
disease progression [19].
Pekel et al. showed that abnormal contrast sen-
sitivity can occur in people with normal visual acu-
ity [25]. Measurement of contrast sensitivity better 
reflects the functional status of the eye compared 
to visual acuity examination using high-contrast 
optotypes [26–28]. 
Porciatti et al. noted that the assessment of contrast 
sensitivity could be a valuable tool for early detection 
and monitoring of visual dysfunction associated with 
pituitary adenomas [29].
Contrast sensitivity test is particularly useful in the 
initial stage of pituitary adenomas, including early 
chiasmal compression, in order to promptly detect 
damage to optic nerve fibres. This examination should 
also be performed in the intermediate stages of pituitary 
adenomas. In patients with large tumours both visual 
acuity and contrast sensitivity are significantly dis-
turbed. Complete contrast sensitivity loss has also been 
observed; such patients are unable to perform this test.
Contrast sensitivity can improve following pituitary 
adenoma resection, especially in patients with smaller 
contrast sensitivity deficits [30].
The greatest benefit of using ROC curves can be 
achieved in patients with pituitary macroadenoma 
detected on NMR but no obvious signs of chiasmal 
compression (Group 2). 
Conclusions
Microperimetry and contrast sensitivity test are non-in-
vasive diagnostic investigations, adjuncts to NMR, 
which allow detection of chiasmal compression in the 
course of pituitary adenoma. They are also important 
for monitoring tumour progression. 
Innovative microperimetry parameters, i.e. MS LN 
and MD LN, reflect changes in the lower-nasal quadrant 
of the retina; they are more sensitive for detection of 
optic chiasm compression compared to MS and MD. In 
contrast sensitivity test, row D and E values are the most 
informative. In comparison to kinetic VF and Octopus 
VF, microperimetry revealed changes in LN quadrant of 
the retina in Group 2. Microperimetry revealed changes 
in LN quadrant of the retina in Group 2 undetected on 
kinetic VF and Octopus VF. 
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